Name
BioPorto Diagnostics
What We Do
Acute Kidney Injury (AKI) adversely impacts 30-70% of critically ill patients with cardiovascular compromise and can be hard to identify with serum creatinine alone. BioPorto’s NGAL tests are based on the NGAL biomarker, which rises within 2 hours of kidney injury, up to 3 days before serum creatinine.
A low NGAL value indicates a low risk of AKI, allowing for confident use of interventions such as fluids, diuretics, or nephrotoxic medications, while an elevated NGAL values signal a high risk of developing AKI.A low NGAL result indicates a low risk of AKI, allowing for confident use of interventions such as fluids, diuretics, or nephrotoxic medications. Elevated NGAL values signal a high risk of developing AKI, triggering nephrology consults and interventions 2-3 days before serum creatinine rises.
Visit booth 1032 to learn how NGAL testing can improve AKI assessment and management in your patients.
A low NGAL value indicates a low risk of AKI, allowing for confident use of interventions such as fluids, diuretics, or nephrotoxic medications, while an elevated NGAL values signal a high risk of developing AKI.A low NGAL result indicates a low risk of AKI, allowing for confident use of interventions such as fluids, diuretics, or nephrotoxic medications. Elevated NGAL values signal a high risk of developing AKI, triggering nephrology consults and interventions 2-3 days before serum creatinine rises.
Visit booth 1032 to learn how NGAL testing can improve AKI assessment and management in your patients.
Website
Categories
Cardiac, Critical Care, Hospital
Address
117 Kendrick Street
Suite 300
NEEDHAM HEIGHTS, MA 02494
United States
Suite 300
NEEDHAM HEIGHTS, MA 02494
United States